Filing Details

Accession Number:
0001209191-13-029242
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-28 19:53:00
Reporting Period:
2013-05-24
Filing Date:
2013-05-28
Accepted Time:
2013-05-28 19:53:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356857 Trius Therapeutics Inc TSRX Pharmaceutical Preparations (2834) 201320630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479790 Philippe Prokocimer C/O Trius Therapeutics, Inc.
6310 Nancy Ridge Dr, # 105
San Diego CA 92121
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-24 12,000 $7.93 86,022 No 4 S Indirect By The Philippe Prokocimer and Maria Prokocimer Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By The Philippe Prokocimer and Maria Prokocimer Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,429 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
  2. The weighted average sales price for the transaction reported was $7.926667, and the range of prices were between $7.92 and $7.96. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided